1. Japan Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Shigematsu Works Co., Ltd.

Shigematsu Works Co., Ltd.

TTSE:7980
850.00
JPY
-11.00
(-1.28%)
6.51BMarket Cap
Nov 05Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
1,271.03
1,398.68
1,506.97
1,467.01
1,518.04
1,511.43
1,630.86
1,785.96
1,676.12
1,810.58
1,827.5
1,984.51
2,192.87
- -
Basic EPS, GAAP
11.21
31.64
46.13
13.75
14.54
6.58
37.39
91.56
82.84
105.22
82.14
109.77
98.75
- -
Free Cash Flow per Basic Share
-16.98
159.9
-6.99
-27.78
-19.77
-6.8
53.27
-49.13
-1.06
80.71
17.75
-278.66
-213.58
- -
Dividend per Share
10
10
10
10.01
12
10
10
9.99
12.51
10.01
14.92
12.54
14.97
- -
Book Value per Share
565.05
607.82
628.82
649.89
672.8
665.92
683.68
790.17
913.63
1,033.33
1,164.76
1,204.45
1,326.95
- -
Tangible Book Value per Share
546.32
590.79
614.02
637.07
659.95
653.91
668.29
776.87
900.68
1,012.9
1,111.97
1,119.57
1,259.87
- -
Basic Weighted Avg Shares
7
7
7
7
7
7
7
7
7
7
7
7
7
7
Sales/Revenue/Turnover
9,120
10,034
10,809
10,510
10,795
10,748
11,597
12,700
11,919
12,876
12,995
14,113
15,593
- -
Operating Margin (%)
2.79
4.68
5.54
0.62
0.85
0.86
2.65
6.48
5.08
7.5
6.04
7.58
6.76
- -
Depreciation Expense
454
379
419
546
676
577
495
538
643
729
567
702
919
- -
Net Income, GAAP
80
227
331
98
103
47
266
651
589
748
584
781
702
- -
Effective Tax Rate (%)
52.16
32.06
31.54
39.68
1.28
41.46
23.27
23.35
26.78
26.84
26.7
24.39
22.88
- -
Profit Margin (%)
0.88
2.26
3.06
0.94
0.96
0.44
2.29
5.13
4.94
5.81
4.49
5.53
4.5
- -
Working Capital
2,104
2,493
2,086
1,855
2,194
2,315
2,450
2,295
3,471
4,217
4,535
3,114
5,223
- -
LT Debt
1,500
1,440
1,041
955
1,207
1,361
1,445
1,436
1,932
1,912
2,039
1,297
4,813
- -
Total Equity
4,054
4,361
4,511
4,623
4,785
4,736
4,862
5,619
6,497
7,348
8,283
8,565
9,436
- -
Return on Invested Capital (%)
1.29
3.62
5.62
0.53
1.18
0.68
2.96
7.27
4.57
6.81
5.18
6.4
5.26
- -
Return on Capital (%)
1.42
3.53
4.95
1.55
1.61
0.73
3.54
7.84
6.38
7.49
5.48
6.49
5
- -
Return on Common Equity (%)
2
5.39
7.46
2.16
2.2
0.98
5.54
12.42
9.72
10.81
7.47
9.27
7.8
- -

Capital Structure

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
ST Debt
2,947
2,821
- -
LT Borrowings
3,210
4,808
- -
LT Finance Leases
- -
5
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
7
7
7
Market Capitalization
5,682
6,514
5,654

Working Capital

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
Total Current Assets
10,254
11,553
- -
Cash, Cash Equivalents & STI
1,430
2,446
- -
Accounts Receivable, Net
1,786
2,859
- -
Inventories
5,111
4,592
- -
Total Current Liabilities
6,154
6,330
- -
Payables & Accruals
- -
- -
- -
ST Debt
2,947
2,821
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.82%
11%
10.17%
Free Cash Flow
-1,044.74%
-1,914.72%
-23.36%
Net Income, GAAP
51.27%
3.83%
-10.04%
Sales/Revenue/Turnover
3.88%
4.38%
10.49%
Total Cash Common Dividend
- -
11.56%
19.42%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
14,113
2026
- -
- -
- -
- -
15,593
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
109.77
2026
- -
- -
- -
- -
98.75
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
12.54
2026
- -
- -
- -
- -
14.97
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Nobuo Shigematsu
Full Time Employees
399
Sector
Health technology
Industry
Medical specialties
Address
1-26-1, Nishigahara Tokyo TY Japan 114-0024
IPO Date
Apr 2, 1963
Website
sts-japan.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Shigematsu Works Co., Ltd. (7980.T) manufactures and sells personal protective equipment (PPE) principally for occupational safety and health in industrial applications. The company offers powered air purifying respirators, particle respirators, gas respirators and chemical cartridge respirators, supplied-air respirators, self-contained breathing apparatus, protective clothing, protective gloves, eye protectors, hearing protectors including ear-muffs and ear-plugs, personal fall-arrest systems, holding stretchers, oxygen meters, and related instruments, chemicals and materials for disaster prevention including escape, firefighting and rescue operations; it also provides maintenance, inspection, repair services for PPE and education on industrial accident prevention. Shigematsu Works serves major customers across government and public offices as well as industries such as textiles, chemicals, oil and gas, automobiles, machinery, electricity, electric power, iron and steel, shipbuilding, heavy industry, fishery, mining, transportation, warehousing, construction, food and healthcare. Founded in September 1917 and headquartered at 1-26-1 Nishigahara, Kita-ku, Tokyo, Japan, the company operates manufacturing plants in Japan including Saitama and Funehiki, with approximately 390 employees and listings on the Tokyo Stock Exchange Standard Market. Shigematsu Works maintains international distribution networks in Asia, Europe, Oceania and beyond, including a new distributor Precision Technologies Pte Ltd added in Singapore as of August 2025. Recent developments include the renewal of products catalogs and issuance of new leaflets such as for the Lambda-Line N95 donning method in March 2024, alongside updates to UKCA and CE certificates by BSI Group in May and December 2025 respectively; the company participated in CiOSH trade shows in 2023 through 2025 and launched new distributors like CleanAIR ApS in Denmark in 2022. In July 2023, it released the new half mask TS01, particle filter YP3R and combined filter YABEK1P3R. No major acquisitions, funding rounds or reorganizations have been reported in the last two years.